 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | anti-CD19 UCAR-T cells / AstraZeneca
New P1 trial, CAR T-Cell Therapy: Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies (clinicaltrials.gov) - Feb 10, 2020
P1, N=30, Not yet recruiting, Sponsor: Xinqiao Hospital of Chongqing